Eletriptan Hydrobromide Patent Expiration
Eletriptan Hydrobromide is Used for treating migraines with or without aura. It was first introduced by Upjohn Manufacturing Ireland Unltd
Eletriptan Hydrobromide Patents
Given below is the list of patents protecting Eletriptan Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Relpax | US6110940 | Salts of an anti-migraine indole derivative |
Aug 29, 2017
(Expired) | Upjohn |
Relpax | US5545644 | Indole derivatives |
Dec 26, 2016
(Expired) | Upjohn |
Eletriptan Hydrobromide's Family Patents
Explore Our Curated Drug Screens
Eletriptan Hydrobromide Generic API Manufacturers
Several generic applications have been filed for Eletriptan Hydrobromide. The first generic version for Eletriptan Hydrobromide was by Zydus Pharmaceuticals Usa Inc and was approved on Jun 16, 2017. And the latest generic version is by Beximco Pharmaceuticals Usa Inc and was approved on Jul 13, 2022.
Given below is the list of companies who have filed for Eletriptan Hydrobromide generic, along with the locations of their manufacturing plants worldwide.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Eletriptan Hydrobromide. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 40MG BASE | tablet | Prescription | ORAL | AB | Aug 29, 2017 |
EQ 20MG BASE | tablet | Prescription | ORAL | AB | Aug 29, 2017 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
2. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Eletriptan Hydrobromide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jan 15, 2019 |
EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jan 15, 2019 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
3. BEXIMCO PHARMS USA
Beximco Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Eletriptan Hydrobromide. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jul 13, 2022 |
EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jul 13, 2022 |
4. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Eletriptan Hydrobromide. Given below are the details of the strengths of this generic introduced by Mylan.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | tablet | Prescription | ORAL | AB | Aug 11, 2017 |
EQ 40MG BASE | tablet | Prescription | ORAL | AB | Aug 11, 2017 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country | City | Firm Name | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||
India |
| |||||||||||||||||
Canada |
| |||||||||||||||||
Ireland |
|
5. STEVENS J
Jerome Stevens Pharmaceuticals Inc has filed for 2 different strengths of generic version for Eletriptan Hydrobromide. Given below are the details of the strengths of this generic introduced by Stevens J.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | May 25, 2018 |
EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | May 25, 2018 |
6. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Eletriptan Hydrobromide. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jun 27, 2017 |
EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jun 27, 2017 |
7. YUNG SHIN PHARM
Yung Shin Pharmaceutical Industrial Co Ltd has filed for 2 different strengths of generic version for Eletriptan Hydrobromide. Given below are the details of the strengths of this generic introduced by Yung Shin Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Jul 13, 2020 |
EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Jul 13, 2020 |
Manufacturing Plant Locations New
Yung Shin Pharm's manufacturing plants are situated in 2 countries - China, Taiwan. Given below are the details of these plant locations as well as the firm names of Yung Shin Pharm as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
China |
| |||
Taiwan |
|
8. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Eletriptan Hydrobromide. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jun 16, 2017 |
EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jun 16, 2017 |